z-logo
Premium
Organic acids of urine in multiple sclerosis
Author(s) -
Steen Göran,
Ransnäs Lennart
Publication year - 1983
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1983.tb04831.x
Subject(s) - excretion , chemistry , glycolic acid , adipic acid , metabolite , succinic acid , urine , medicine , creatinine , terpenoid , organic acid , endocrinology , lactic acid , biochemistry , chromatography , organic chemistry , biology , bacteria , genetics
The urinary excretion of organic acids was examined in 50 cases with multiple sclerosis and in 50 age‐ and sex‐matched controls. The concentrations of the acids were related to creatinine. No differences were found for compounds such as glycolic acid, 2‐methyl‐3‐hydroxybutyric acid, 2‐ethylhydracrylic acid, 4‐hydroxyphenylacetic acid, suberic acid and many other acids. However, the mean excretion of 2‐hydroxy‐2‐methyl‐3‐butenoic acid was increased two‐fold in the MS group. 2 MS cases had a very high excretion of 3‐methylglutaconic acid, and another 6 cases had moderate elevations, which were fairly constant over a time period of several months. Moderate elevations were also noted in 2 healthy controls. 1 MS case had a very high excretion of 3‐hydroxyisovaleric acid. 7 MS cases, and none in the control group, had elevated excretion of adipic acid. Differences were also noted for lactic acid, succinic acid, aconitic acid and 3‐methyladipic acid. An oral dose of deuterium‐labelled acetate was given to one of the patients with high excretion of 3‐methylglutaconic acid. Deuterium was incorporated into this metabolite. 3‐methylglutaconic acid, 2‐hydroxy‐2‐methyl‐3‐butenoic acid, 3‐hydroxyisovaleric acid and 3‐methyladipic acid are all potential isoprenoid metabolites. A possible defect in the pathway of isoprenoid biosynthesis is discussed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here